 | Nvidia's 3 Secret Partners (ad)AI is creating 1,600 new millionaires every single day. At the center of this frenzy sits Nvidia, now valued at $4.5 trillion. But most investors don't know Nvidia has three secret partners, smaller companies that play almost impossible-to-replicate roles in GPU development. Without them, Nvidia's business would be hamstrung. Because they're largely ignored, these companies trade at far more attractive valuations, giving you a way to capitalize on Nvidia's dominance without buying Nvidia itself. This is a pivotal moment for AI, but winning this trend requires playing smart, not reckless. See the full 2026 AI investment playbook and all three secret partners. |
|
Today's Top Stories | | By Dan Schmidt | January 28, 2026 08:18 AM |
| | By American Hartford Gold |
| | By Leo Miller | January 28, 2026 07:19 AM |
| | By Leo Miller | January 28, 2026 06:13 AM |
| | By American Hartford Gold |
| | By Jordan Chussler | January 27, 2026 05:05 PM |
| | By Thomas Hughes | January 27, 2026 08:16 AM |
|
|
Your Watchlist | | - No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today.
| | | |
| Manage Your Watchlist
|
Analysts' Upgrades | | KKR & Co. Inc. (NYSE:KKR) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $144.00 price target on the stock. This represents a 23.1% upside from the current price of $116.94. | | Microchip Technology (NASDAQ:MCHP) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $95.00 price target on the stock. This represents a 17.9% upside from the current price of $80.56. | | Synchrony Financial (NYSE:SYF) was upgraded by analysts at Compass Point from a "neutral" rating to a "buy" rating. They now have a $96.00 price target on the stock. This represents a 29.4% upside from the current price of $74.17. | | Texas Instruments (NASDAQ:TXN) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $235.00 price target on the stock, up previously from $185.00. This represents a 11.0% upside from the current price of $211.77. | | United Parcel Service (NYSE:UPS) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.The current price is $106.40. | | Visa (NYSE:V) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $385.00 price target on the stock. This represents a 18.2% upside from the current price of $325.69. |
| View More Upgrades
|
 | Buy AES Immediately (ad)A widely followed Wall Street analyst is highlighting AES Corp (AES) as a stock to watch right now, based on signals from his proprietary Power Gauge system. The model tracks factors like momentum, financial strength, and institutional activity across thousands of U.S. stocks.
He breaks down the full reasoning in a short briefing, including why AES is showing unusual strength at this stage of the market. See the full analysis here  |
|
Analysts' Downgrades | | Banco Bilbao Viscaya Argentaria (NYSE:BBVA) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.The current price is $25.35. | | Capital City Bank Group (NASDAQ:CCBG) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating. They now have a $45.00 price target on the stock. This represents a 11.2% upside from the current price of $40.47. | | Coca Cola Femsa (NYSE:KOF) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $100.00 price target on the stock. This represents a 5.6% downside from the current price of $105.94. | | Plains All American Pipeline (NYSE:PAA) was downgraded by analysts at Bank of America Corporation from a "neutral" rating to an "underperform" rating. They now have a $19.00 price target on the stock. This represents a 3.2% downside from the current price of $19.63. | | Plains GP (NYSE:PAGP) was downgraded by analysts at Bank of America Corporation from a "neutral" rating to an "underperform" rating. They now have a $19.00 price target on the stock. This represents a 8.6% downside from the current price of $20.79. | | PRA Group (NASDAQ:PRAA) was downgraded by analysts at Citizens Jmp from a "mkt outperform" rating to a "market perform" rating.The current price is $14.38. | | PayPal (NASDAQ:PYPL) was downgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "sell" rating. They now have a $50.00 price target on the stock. This represents a 8.7% downside from the current price of $54.77. | | Rio Tinto (NYSE:RIO) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.The current price is $93.15. | | Roper Technologies (NASDAQ:ROP) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.The current price is $359.60. | | Western Alliance Bancorporation (NYSE:WAL) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $105.00 price target on the stock. This represents a 18.0% upside from the current price of $88.95. |
| View More Downgrades
|
 | The Next Big AI Application: Buy These Three Stocks (ad)This coming Wednesday, January 28, at 8 p.m. ET, Jeff Brown is having a special online strategy session he's calling 24-Hour AI Fortunes…
Where he will recommend THREE new trades to take advantage of a strange phenomenon…
That has delivered gains big enough to turn $10,000 into $101,700… $151,600, and even a mind-blowing $650,000… all in a 24-hour period. Click here to save your seat.  |
|
Analysts' New Coverage | | Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $527.00 price target on the stock. This represents a 48.5% upside from the current price of $354.97. | | Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $24.00 price target on the stock. This represents a 4.2% upside from the current price of $23.03. | | BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.The current price is $77.17. | | Bloom Energy (NYSE:BE) is now covered by analysts at China Renaissance. They set a "buy" rating and a $207.00 price target on the stock. This represents a 29.0% upside from the current price of $160.47. | | BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $80.00 price target on the stock. This represents a 41.8% upside from the current price of $56.44. | | Celestica (NYSE:CLS) (TSE:CLS) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $400.00 price target on the stock. This represents a 17.6% upside from the current price of $340.11. | | Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $87.00 price target on the stock. This represents a 35.0% upside from the current price of $64.43. | | Companhia Paranaense de Energia - Copel (NYSE:ELPC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $10.40 price target on the stock. This represents a 2.0% downside from the current price of $10.61. | | 4D Molecular Therapeutics (NASDAQ:FDMT) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $33.00 price target on the stock. This represents a 281.3% upside from the current price of $8.66. | | GE Vernova (NYSE:GEV) is now covered by analysts at China Renaissance. They set a "buy" rating and a $966.00 price target on the stock. This represents a 37.8% upside from the current price of $700.92. | | Ionis Pharmaceuticals (NASDAQ:IONS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $95.00 price target on the stock. This represents a 15.7% upside from the current price of $82.13. | | Moderna (NASDAQ:MRNA) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $25.00 price target on the stock. This represents a 44.9% downside from the current price of $45.39. | | Raymond James Financial (NYSE:RJF) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $191.00 price target on the stock. This represents a 13.3% upside from the current price of $168.60. | | Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $20.00 price target on the stock. This represents a 8.0% downside from the current price of $21.73. | | Entrada Therapeutics (NASDAQ:TRDA) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $21.00 price target on the stock. This represents a 88.7% upside from the current price of $11.13. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
Post a Comment
Post a Comment